07 Jan 2001

Collomack® (Collomack® Lösung) - Deutschland

Updated: 07 Jan 2001

Collomack®

Hyperkeratosen, Hühneraugen, Schwielen, Warzen.

Collomack® Description, Presentation and Dosage

Collomack® Description

Collomack® Drug Class Description

Kombinationen

Collomack® Drug Description

10 g enth.: Salicylsäure 2 g, Milchsäure 0,5 g, Polidocanol 0,2 g.

Collomack® Generic Name

Collomack® Lösung

Collomack® Presentation

Collomack® Presentation

Collomack®

Collomack® Manufacturer

Mack, Illert.

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

Collomack® Dosage

Collomack® Adult Dosage

Dibutylphthalat, Ethylcellulose, Aceton.

Collomack® Precautions, Reactions and Contraindications

Collomack® Special Precautions

Collomack® Adverse Reactions

Collomack® Adverse Reactions

S 5

Related Drugs - Dermatology

Back to top